abstract |
The present invention relates to a dosage form for transmucosal administration comprising a therapeutically effective amount of aliskiren or a pharmaceutically acceptable salt thereof and an excipient for transmucosal delivery, wherein the active ingredient is the total weight of the dosage form. Present in an amount of 0.001 to 80% by weight). |